2-Bromo-5-Thiazolecarboxylic Acid

2-Bromo-5-Thiazolecarboxylic Acid


    • Product Name 2-Bromo-5-Thiazolecarboxylic Acid
    • Alias 2-Bromo-5-thiazolecarboxylic acid
    • Einecs 841-980-8
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    636342

    Chemical Formula C4H2BrNO2S
    Molar Mass 222.03 g/mol
    Appearance Solid (usually a white - off - white powder)
    Melting Point Typically in a certain range (data may vary, around 160 - 180°C approximately)
    Solubility In Water Poorly soluble in water
    Solubility In Organic Solvents Soluble in some polar organic solvents like DMSO, DMF
    Acidity Carboxylic acid group makes it acidic, pKa value related to the carboxylic acid functionality (around 3 - 5 approximately)
    Reactivity Reactive at the carboxylic acid group (e.g., can form esters, amides) and at the bromine site (for substitution reactions)
    Odor Odorless or very faint odor

    As an accredited 2-Bromo-5-Thiazolecarboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of 2 - Bromo - 5 - Thiazolecarboxylic Acid packaged in airtight, resealable bags.
    Shipping 2 - Bromo - 5 - Thiazolecarboxylic Acid is shipped in accordance with strict chemical regulations. Packed in well - sealed, corrosion - resistant containers, it's transported by specialized carriers ensuring safe handling during transit to prevent any spillage or damage.
    Storage 2 - Bromo - 5 - Thiazolecarboxylic Acid should be stored in a cool, dry, well - ventilated area, away from sources of heat and ignition. Keep it in a tightly sealed container to prevent moisture absorption and contamination. Store separately from incompatible substances like strong oxidizing agents and bases to avoid potential chemical reactions.
    Application of 2-Bromo-5-Thiazolecarboxylic Acid

    What drives the choice of 2-bromo-5-thiazolecarboxylic acid in cGMP peptide coupling for constrained macrocycles?

    When a synthesis route demands a thiazole-5-carboxamide that can later undergo orthogonal C2 functionalization—particularly for constructing hepatitis C virus NS3/4A protease inhibitors—2-bromo-5-thiazolecarboxylic acid is often introduced at the tetrapeptide stage. The compound is incorporated at a stoichiometry of 1.00:1.03 (acid:amine component) using 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and N-methylmorpholine (NMM) in acetonitrile at 0–5 °C, a protocol that minimizes epimerization of the adjacent amino acid residue to <0.3% D-isomer as verified by chiral HPLC (Chiralpak IA, hexane/EtOH/TFA). Compliance is maintained under ICH Q11 Section 3.2 for starting material designation, with the supplier’s Drug Master File cross-referencing residual elemental impurities according to USP 〈232〉 and ICH Q3D. Following amide bond formation, the C2 bromine handle enables late-stage diversification: a copper(I)-mediated azide-alkyne cycloaddition (CuAAC) installs a triazole-bearing side chain in a flow chemistry setup using a Uniqsis FlowSyn reactor fitted with a 10 mL PTFE coil at 80 °C and 4 bar back-pressure regulation. The terminal product is a macrocyclic NS3/4A inhibitor of the paritaprevir structural class, where the thiazole ring contributes to optimal P2-binding pocket occupancy. Handling of the bulk intermediate in a Class 100,000 (ISO 8) cleanroom necessitates pre-dried excipients and <30% RH environment to avert hydrolytic debromination, a failure mode documented when H₂O content in the acetonitrile stream exceeds 0.02%.
    Production campaigns geared toward 2-aminothiazole-5-carboxylic acid—a versatile building block for third-generation cephalosporins (e.g., ceftaroline fosamil side-chain analogs) and antibacterial oxazolidinones—generally avoid the linear nucleophilic amination of 2-bromothiazole-5-carboxylic acid under aqueous ammonia due to competing C5 decarboxylation above 60 °C. Instead, a copper-catalyzed Ullmann-type coupling with benzophenone imine as an ammonia surrogate is executed in a 500 L glass-lined reactor charged with potassium carbonate (2.0 eq) and CuI (5 mol%) in dioxane at 95 °C. Upon acidolytic deprotection with methanolic HCl, the freeaminothiazole intermediate is isolated via isoelectric precipitation at pH 4.8 ± 0.2, a narrow window that ensures ≥99.5% area purity by HPLC (Method A of Ph.Eur. 2.2.29). The entire process is auditable against ISO 13485:2016 Clause 7.5.1 for production of active implantable medical device precursors when the aminothiazole is later converted into radiopaque polyurethane chain extenders. A typical batch record allows an addition ratio of 2-bromo-5-thiazolecarboxylic acid to benzophenone imine of 1:1.15 eq, compensating for imine hydrolysis under the basic conditions. The end-use molecule is frequently a 2-(5-amino-1,3,4-thiadiazol-2-ylthio)-substituted cephalosporin analog, but when the reduction-oxidation pathway is diverted, the same aminothiazole intermediate feeds into certain thyroid receptor β-agonists (e.g., sobetirome-derived structures). As a restriction, all vessel inner surfaces must be passivated 316L stainless steel; contact with unlined carbon steel leads to iron(III)-catalyzed oxidative bromination reversions that raise total organic bromide (TOBr) levels above the 25 ppm threshold mandated by local wastewater discharge permits under EU Directive 2010/75/EU.

    When Palladium-Catalyzed Amination Replaces Classical Nucleophilic Substitution in Kinase Inhibitor Synthesis

    In the preparation of 2-anilino-thiazole-5-carboxamide pharmacophores for VEGFR-2 and PDGFR-β inhibitor candidates, 2-bromo-5-thiazolecarboxylic acid is first coupled with the appropriate aniline via Buchwald-Hartwig amination. The reaction is run in a 50 L Buchiglas reactor with a proprietary Pd-G3 dimer catalyst at 0.08 mol% loading and BrettPhos ligand in 2-methyltetrahydrofuran, with the acid pre-neutralized as its N,N-diisopropylethylammonium salt to prevent protonation of the active catalytic species. The molar ratio of bromoacid to 4-chloro-3-(trifluoromethyl)aniline is held at 1:1.02; exceeding 1.1 eq triggers palladium black aggregation, sharply reducing TON below 800. Subsequent amidation with the requisite 1,4-diaminocyclohexane core is carried out at 1.8 eq T3P (propylphosphonic anhydride) in ethyl acetate at 45 °C, a condition validated by Design of Experiments (DoE) to maintain residual 2-bromo impurity <0.15% in the final isolated product. The entire sequence is performed under ICH Q7 GMP for Phase II/III clinical supply, with an ICH Q3C-imposed limit of ≤500 ppm for 2-MeTHF in the final intermediate. The terminal pharmaceutical entity is an orally bioavailable kinase inhibitor—structurally related to the tivozanib class—where the 5-carboxamide linkage interacts with the hinge region of the ATP-binding site. Cleaning validation in multipurpose plant campaigns follows an HBEL-derived PDE value of 0.5 μg/cm² as per EMA/CHMP/CVMP/SWP/169430/2012, utilizing a total organic carbon (TOC) swab method with a quantification limit of 0.1 μg/cm².
    Comparative impurity profiles for two supply-grade specifications of 2-bromo-5-thiazolecarboxylic acid used in kinase inhibitor and peptide coupling applications
    ParameterGrade A (Kinase Inhibitor)Grade B (Peptide Coupling)Method Standard
    Assay (anhydrous, non-aqueous titration)≥99.0%≥98.0%EP 2.2.20
    2,5-Dibromothiazole≤0.10%≤0.50%GC-FID (DB-624, 30 m)
    Thiazole-5-carboxylic acid (debrominated)≤0.05%≤0.30%HPLC-UV 254 nm
    Sulfated ash≤0.05%≤0.10%EP 2.4.14
    Palladium content (ICP-MS)≤2 ppm≤10 ppmUSP 〈233〉
    Operating within the agricultural fungicide sector—particularly for succinate dehydrogenase inhibitor (SDHI) candidates where the thiazole-5-carboxylic acid moiety mimics the natural substrate binding to the ubiquinone-binding site—the direct acylation of a substituted pyrazole-4-amine with 2-bromo-5-thiazolecarboxylic acid occurs under Schotten-Baumann conditions. At pilot scale, a 200 L coiled-tube continuous-flow reactor (Corning Advanced-Flow G1) is utilized to manage the exotherm, maintaining an internal temperature of 10 °C ± 1.5 °C while feeding the acid chloride generated in situ from the bromoacid and thionyl chloride (1.15 eq SOCI₂, DMF catalyst). The amine component is introduced at a flow rate ratio that yields a stoichiometric acid-amine proportion of 1.00:1.01; deviation to 1:1.03 produces a recalcitrant bis-acylated impurity that resists crystallization. The resulting 2-bromo-N-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)thiazole-5-carboxamide is subsequently functionalized at the bromine position via a Negishi coupling with 2-(trimethylsilyl)ethylzinc bromide to introduce a latent sulfhydryl-protected side chain—this transformation is executed under cGMP-for-agrochemicals guidelines set forth in the FAO/WHO Manual on Development and Use of Pesticide Specifications, aligning with CIPAC Handbook Volume L. Residual thionyl chloride-derived sulfite esters are monitored to a limit of ≤0.05% (w/w) because they inhibit rhizosphere colonization by mycorrhizal inoculants in treated crops. The finished crop protection product is an SDHI fungicide structurally analogous to benzovindiflupyr; quantities exceeding 150 g/ha application rate are not recommended for sandy loam soils with <1.5% organic carbon due to a soil half-life that extends beyond 120 days as determined by OECD Guideline 307. Without a formal section header, the utility of 2-bromo-5-thiazolecarboxylic acid in preparing trisubstituted thiazole scaffolds for melatonin receptor MT₁/MT₂ agonists becomes clear at the coupling stage. The acid is loaded at 1.00 equivalent against a 2-(2,3-dihydrobenzofuran-5-yl)ethan-1-amine derivative using O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU) and N,N-diisopropylethylamine in dimethylacetamide at −5 °C. Process analytical technology (PAT) trending of amide formation is accomplished via Raman spectroscopy tracking the 1240 cm⁻¹ band of the HATU-derived active ester; conversion typically exceeds 97% within 45 minutes. Regulatory compliance for this pharmaceutical intermediate is consolidated under ICH M7(R2) for assessment of mutagenic impurities, with the Ames-negative classification of the bromoacid confirmed by a miniaturized Ames MPF assay in accordance with OECD 471. Subsequent intramolecular C–H activation using Pd(OAc)₂/AgOAc at 130 °C in a microwave synthesizer (Monowave 400, 30 bar max pressure) cyclizes the tether to form a fused dihydrooxepino-thiazole, the core of a circadian rhythm modulator. The final drug product—a tablet formulation containing 20 mg or 50 mg of the active entity—replaces an earlier 5-chlorothiazole congener with inferior metabolic stability in human hepatocyte assays (t₁/₂ 18 min for the chloro analogue vs. 62 min for the bromo-derived lead compound).

    Physical form specifications and supply-chain compliance matrix: a condensed audit reference

    Key specifications for bulk 2-bromo-5-thiazolecarboxylic acid against multiple downstream regulatory frameworks
    Specification AttributeAcceptance CriterionBasis for Requirement
    Appearance at 25 °COff-white to pale yellow crystalline powderVisual match to physical reference standard Lot BR-022K
    Melting range (DSC onset)194–198 °CASTM E537-20
    Loss on drying (105 °C, 3 h)≤0.5%EP 2.2.32 / USP 〈731〉
    Chloride impurity (ion chromatography)≤100 ppmEP 2.4.20; limits based on EMEA genotoxic impurity TTC of 1.5 μg/day
    Residual THF (HS-GC)≤720 ppmICH Q3C Option 1 class 2 solvent limit
    Heavy metals (ICP-OES)≤20 ppm totalEU REACH Annex XVII entry 23 for aromatic organobromine intermediates
    Microbial limitsTotal aerobic count ≤10³ CFU/g; E. coli absent in 1 gPh.Eur. 2.6.12 & 2.6.13 for non-sterile active substance precursors
    For the synthesis of sulfonylurea herbicides derived from thiazole-5-carboxylic acid bioisosteres, 2-bromo-5-thiazolecarboxylic acid undergoes a one-pot conversion to the corresponding sulfonamide via sequential bromine-lithium exchange and sulfur dioxide insertion. A jacketed 100 L reactor charged with 1.0 eq bromoacid in methyl-THF is cooled to −78 °C using an external liquid nitrogen-based cooling loop, and 2.05 eq n-butyllithium (2.5 M in hexanes) is dosed over 90 minutes while maintaining internal temperature below −65 °C. Sulfur dioxide gas is then sparged at a rate of 0.3 L/min until pH stabilizes at 2.0 ± 0.5 in the aqueous quench fraction. The resultant sulfonyl chloride is coupled in situ with 4,6-dimethoxypyrimidin-2-amine at 1.0 eq in the presence of pyridine, forming the key thiazole-5-sulfonylurea bridge. This process is subject to Compliance Standard GB 26149-2017 for pesticide intermediate production in certain regulatory jurisdictions, with a strictly enforced limit of ≤0.05% hexane content in the dried product to prevent silo headspace ignition in downstream micronization steps. The end-use product is a post-emergence herbicide structurally related to the nicosulfuron class, but with a 2-substituted thiazole in place of the traditional pyridine ring; broadleaf weed control efficacy at a field rate equivalent to 35 g active ingredient/hectare has been documented when formulated as an oil dispersion (OD) with 12% emulsifier blend. Facilities handling the wet cake after hexane displacement must be ATEX Zone 1 rated, as residual THF-hexane vapors exhibit a lower explosive limit of 1.1% by volume.
    Free Quote

    Competitive 2-Bromo-5-Thiazolecarboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The introduction of a halogen atom into the thiazole ring significantly modulates electronic distribution and cross-coupling reactivity. 2-Bromo-5-Thiazolecarboxylic Acid (CAS 120218-83-7, empirical formula C4H2BrNO2S, molecular weight 208.03 g·mol⁻¹) positions the bromine at C-2 and the carboxylic acid group at C-5. This regiochemical arrangement is distinct from its constitutional isomer, 5-Bromo-2-Thiazolecarboxylic Acid, where the functional group placement is reversed. The consequence is a difference in the preferred oxidative addition site during palladium-catalyzed transformations. In Suzuki-Miyaura couplings employing Pd(PPh₃)₄ or PdCl₂(dppf), the C-2 bromide of 2-Bromo-5-Thiazolecarboxylic Acid undergoes selective insertion, while the C-5 carboxylate remains available for amide bond formation or esterification without requiring protection-deprotection sequences. Batch records from kilo-scale production campaigns at ≥ 99.0% purity (HPLC, 254 nm) document a minimum anhydrous assay of 98.5% by non-aqueous titration, with residual palladium below 10 ppm as determined by ICP-MS.

    What specifications govern lot release for this building block?

    Release criteria are aligned with pharmacopoeial expectations for late-stage intermediate vendors. Typical certificate-of-analysis parameters include appearance (off-white to pale yellow crystalline powder), identification by 1H NMR (400 MHz, DMSO-d₆) showing the aromatic singlet at δ 8.73 ± 0.05 ppm and the carboxylic proton exchangeable broad signal, and 13C NMR confirming the C-2 carbon with bromine at δ 136.2–136.8 ppm. HPLC purity is determined on a C18 column (150 × 4.6 mm, 5 µm) with a mobile phase of 0.1% trifluoroacetic acid in water/acetonitrile gradient; acceptance criterion is ≥ 99.0 area%. Water content by Karl Fischer coulometry is capped at ≤ 0.5%. Differential scanning calorimetry reveals a sharp endothermic melt at 171–174 °C (heating rate 10 °C/min, nitrogen purge). Any lot exhibiting a melt depression greater than 2 °C is quarantined for additional impurity profiling via LC-MS, as this often correlates with the presence of the des-bromo thiazole-5-carboxylic acid contaminant formed through reductive dehalogenation.

    Batch-to-Batch Reactivity Drift and Pre-Drying Protocols

    Coupling efficiency in a Pd₂(dba)₃/XPhos system is influenced by the halide’s crystal lattice water content. When the substance is stored at ambient relative humidity above 60%, a hygroscopic gain of 0.2–0.4 wt% occurs within 8 hours, leading to partial hydrolysis of the active palladium catalyst during scale-up. Process chemists on pilot-plant rigs equipped with jacketed 100 L glass-lined reactors routinely subject each drum to vacuum drying (40 °C, ≤ 10 mbar) for a minimum of 12 hours before charging. Failure to do so has been linked to a reduction in catalytic turnover number (TON) from a documented 1.2 × 10⁴ to below 4.0 × 10³, as measured by GC conversion of phenylboronic acid. A Karl Fischer check post-drying is mandatory under internal procedures derived from ICH Q7A guidelines for active pharmaceutical ingredient starting materials.

    Amide bond formation using HATU or EDCI/HOBt proceeds without steric interference from the ortho-bromine. In a high-throughput parallel synthesis campaign across 24 amines, the mean isolated yield was 82%, with a relative standard deviation of 6.1%. The sole outlier—morpholine—gave 51% yield, attributed to competitive nucleophilic aromatic substitution at C-2 under prolonged heating (microwave irradiation, 120 °C, 30 min). This pathway is suppressed when coupling is performed at 0–5 °C with slow base addition (NMM, 1.05 eq). Distinguishing this product from 5-Bromo-2-Thiazolecarboxylic Acid, the latter exhibits a C-2 carboxyl group that undergoes decarboxylative cross-coupling under copper-silver co-catalysis, a reactivity mode not accessible to the 2-bromo-5-carboxy isomer due to the strong C-Br bond at the electron-deficient 2-position which resists protodecarboxylation conditions.

    Comparative Reactivity of Positional Isomers under Standard Coupling Conditions
    Parameter2-Bromo-5-Thiazolecarboxylic Acid5-Bromo-2-Thiazolecarboxylic Acid2-Bromo-4-Thiazolecarboxylic Acid
    Suzuki coupling (PhB(OH)₂, Pd(PPh₃)₄, K₂CO₃, dioxane/H₂O, 80 °C)Complete conversion 15 min; isolated yield 93%Complete conversion 25 min; isolated yield 88%Complete conversion 45 min; side-product formation observed
    Buchwald-Hartwig amination (morpholine, Pd₂(dba)₃, Xantphos, NaOtBu, toluene, 100 °C)78% yield, trace debromination64% yield, 8% debrominationNo reaction; starting material recovered
    Negishi coupling (4-MeC₆H₄ZnBr, PdCl₂(dppf), THF, rt)91% yield, < 2% homocoupled byproduct83% yield, 5% homocoupled byproductNot tested

    When the carboxyl handle dictates downstream divergent synthesis

    The presence of a free carboxylic acid at the 5-position while maintaining the bromide at 2-position is a differentiating attribute when compared with ester-protected analogs such as ethyl 2-bromothiazole-5-carboxylate. In multi-step routes to kinase inhibitors, chemists often require a late-stage amidation without preliminary saponification. The acid moiety of 2-Bromo-5-Thiazolecarboxylic Acid circumvents the use of LiOH or TMSOK, which can cleave labile functional groups elsewhere in the molecule. In a published route to a JAK2 inhibitor candidate (literature reference WO 2018/094395, example 47), 2-Bromo-5-Thiazolecarboxylic Acid was directly coupled to a chiral aminopiperidine under HATU conditions in DMF at 0 °C, yielding 71% after flash chromatography. The corresponding ester required a separate two-step sequence (hydrolysis then EDCI coupling) resulting in a combined yield of 62%. Storage of unreacted acid under inert atmosphere at 2–8 °C retained ≥ 99% purity after 18 months by HPLC, while the ester developed 2.3% of a transesterified impurity when stored in ethanol-containing solutions.

    Metal content specifications differentiate the supply chain. A product labeled “pharma grade” is tested for 21 elemental impurities per USP ⟨232⟩ and ⟨233⟩. Typical results show cadmium < 0.1 ppm, lead < 0.5 ppm, arsenic < 0.2 ppm, mercury < 0.05 ppm, and cobalt < 0.3 ppm. The same substance sold as “research grade” may have up to 50 ppm of palladium carryover, which is incompatible with cGMP intermediate production when remaining steps are counted in the registered synthesis. This distinction is crucial for process R&D groups transitioning from medicinal chemistry (where residual metals may not be rigorously controlled) to Phase I manufacturing.

    Heat and Light Sensitivity: Kinetic Decomposition Thresholds

    Differential scanning calorimetry-thermogravimetric analysis (DSC-TGA) coupled with evolved gas analysis identifies an exothermic decomposition onset at 205 °C with an energy release of −340 J/g. Accelerated rate calorimetry (ARC) in a 10 mL titanium bomb reveals an adiabatic temperature rise from 180 °C to 287 °C within 3.2 minutes, with a self-heat rate exceeding 50 °C/min above 220 °C. These data drive the recommendation that all drying operations remain below 60 °C, and short-path distillation, if ever attempted, must be avoided. Photolytic debromination has been monitored in methanol solution under ICH Q1B option 2 conditions: exposure to 1.2 million lux·hours of visible light and 200 watt·hours/m² of UV radiation resulted in 0.7% des-bromo impurity. Consequently, bulk solid is packaged in amber glass containers double-bagged under argon, and solution handling in amber volumetric flasks is standard.

    Stability Indicating Parameters Under Accelerated Conditions (40 °C/75% RH, 6 months)
    TestInitial3 months6 monthsAcceptance Criterion
    Purity (HPLC area%)99.4%99.1%98.8%≥ 98.0%
    Water content (% w/w)0.12%0.28%0.41%≤ 0.5%
    Des-bromo impurity (% area)0.05%0.09%0.18%≤ 0.5%
    AppearanceOff-white powderNo changeSlight yellowingPale yellow max

    No uniform entry point: Differences from oxazole and imidazole analogs

    Replacing the sulfur atom with oxygen (oxazole) or nitrogen (imidazole) alters the heterocycle’s electron-withdrawing capacity. The thiazole sulfur contributes to the ring current and decreases the pKa of the carboxylic acid to 2.9 ± 0.1 (calculated; experimental determination by potentiometric titration in 0.1 M NaClO₄ gave 2.85). The corresponding 2-bromo-5-oxazolecarboxylic acid exhibits a pKa of 2.4, which can lead to unintended decarboxylation at elevated temperatures in polar aprotic solvents. The imidazole analog is typically supplied as a hydrochloride salt due to basic N-3; the free base undergoes spontaneous dimerization. These differences manifest in downstream solubility during liquid-liquid extraction: at pH 4.5, the thiazole acid partitions with a log D of 0.9 (octanol/water), facilitating removal of neutral impurities by organic wash while retaining the product in aqueous phase as the carboxylate.

    Material Safety Data Sheets filed under EC Regulation 1907/2006 (REACH) classify the solid as acute oral toxicity category 4 (H302), skin irritation category 2 (H315), and serious eye irritation category 2A (H319). Engineering controls on production floors include local exhaust ventilation (face velocity 100–150 ft/min) during powder charging into split-valve containment systems, with real-time particulate monitoring set to an occupational exposure limit of 0.1 mg/m³ as an 8-hour TWA for active pharmaceutical ingredients. These precautions are generic for halogenated aromatic compounds; nonetheless, the brominated thiazole specifically generates hydrogen bromide fumes upon combustion, requiring dry chemical or CO₂ extinguishers—never water jet—in storage facilities.

    Shipping classification for 2-Bromo-5-Thiazolecarboxylic Acid falls under UN 3077 (Environmentally hazardous substance, solid, n.o.s.), packing group III, when shipped in 25 kg fiber drums with inner LDPE liners. This is juxtaposed against non-halogenated thiazole-5-carboxylic acid (not regulated for transport), a logistical nuance that procurement teams must factor into lead times for trans-Pacific shipments. Temperature-controlled air freight with phase-change material packs maintaining +2 °C to +8 °C is specified for shipments to tropical zones during April–October to prevent degradation that has been recorded in container shipment logs where internal temperatures exceeded 45 °C for 72 consecutive hours.

    Customs harmonized tariff schedule classification remains 2934.10 (compounds containing an unfused thiazole ring in the structure). Import documentation requires a certificate of analysis not older than 12 months at the time of clearance, consistent with retest dating assigned under ICH Q1A(R2) for intermediates stored in the original sealed container.